XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Research and development, net $ (1,417) $ (1,365) $ (2,586) $ (2,982)
General and administrative, net (1,094) (959) (2,309) (2,261)
Operating loss (2,511) (2,324) (4,895) (5,243)
Financing income, net 46 37 59 103
Net loss $ (2,465) $ (2,287) $ (4,836) $ (5,140)
Basic net loss per share $ (0.17) $ (0.25) $ (0.33) $ (0.60)
Diluted net loss per share $ (0.17) $ (0.25) $ (0.33) $ (0.60)
Basic weighted average common shares outstanding 14,846,584 9,198,806 14,451,279 8,609,325
Diluted weighted average common shares outstanding 14,846,584 9,198,806 14,451,279 8,609,325